Makzid T 500mg/62.5mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Ceftazidime (500mg) + Tazobactum (62.5mg)
Overview Makzid T 500mg/62.5mg Injection
Tazicef 500mg/62.5mg Injection is a dual-action medication used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must be solely under a physician's guidance. Adhere strictly to the prescribed dosage schedule; complete the entire course regardless of symptom improvement. Premature cessation may compromise efficacy. Minor side effects, including nausea, vomiting, diarrhea, and dyspepsia, may occur. Report any worsening symptoms immediately. Seek immediate medical attention for allergic reactions (e.g., skin rashes, itching, edema, respiratory distress). Inform your doctor of all current medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if experiencing somnolence or dizziness. Prioritize rest, nutrition, and hydration for optimal recovery. Your doctor may order blood tests and other diagnostics to monitor treatment response.
Uses of Makzid T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Makzid T 500mg/62.5mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Makzid T 500mg/62.5mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Makzid T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Makzid T 500mg/62.5mg Injection works:
Ceftazidime/Tazobactam (Makzid T 500mg/62.5mg Injection) combines a cephalosporin antibiotic with a beta-lactamase inhibitor to combat bacterial infections. Ceftazidime's mechanism involves disrupting bacterial cell wall synthesis, hindering their survival. Tazobactam's role is to counter bacterial resistance mechanisms, thereby boosting Ceftazidime's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Makzid T 500mg/62.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Makzid T 500mg/62.5mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or absent negative impacts on fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Makzid T 500mg/62.5mg presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no discernible threat to the infant.
DrivingUNSAFE
The injection Makzid T 500mg/62.5mg can reduce alertness, impair vision, and induce drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
For individuals with impaired kidney function, the administration of Makzid T 500mg/62.5mg Injection requires careful monitoring. Dosage modification of Makzid T 500mg/62.5mg Injection might be necessary. A physician's guidance is recommended.
LiverCAUTION
Patients with severe hepatic impairment should use Makzid T 500mg/62.5mg Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Makzid T 500mg/62.5mg Injection :
Omit a Makzid T 500mg/62.5mg Injection dose? Seek medical advice immediately.
Facts to Know About Makzid T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Antimicrobial Agents |
3,018 People bought this recently